P3 Health Partners Stock Filter Stocks by Fundamentals
| PIII Stock | USD 6.65 0.04 0.61% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess P3 Health's long-term financial health and intrinsic value.
PIII | Shares Owned by Insiders | Build AI portfolio with PIII Stock |
P3 Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of P3 Health from analyzing P3 Health's financial statements. These drivers represent accounts that assess P3 Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of P3 Health's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 7.7M | 5.9M | 1.5M | 653.1K | 751.1K | 713.5K | |
| Enterprise Value | 20.5M | (44.7M) | 89.9M | 128.0M | 115.2M | 121.0M |
P3 Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, P3 Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to P3 Health's managers, analysts, and investors.Environmental | Governance | Social |
P3 Health Institutional Holders
Institutional Holdings refers to the ownership stake in P3 Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of P3 Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing P3 Health's value.| Shares | Moneta Group Investment Advisors Inc | 2024-12-31 | 112.8 K | State Street Corp | 2024-12-31 | 101.4 K | Northern Trust Corp | 2024-12-31 | 100 K | Welch Capital Partners Llc | 2025-03-31 | 90 K | Hrt Financial Llc | 2024-12-31 | 71.3 K | Pnc Financial Services Group Inc | 2024-12-31 | 68.7 K | Point72 Asia (singapore) Pte. Ltd | 2024-12-31 | 33.2 K | Engineers Gate Manager Lp | 2024-12-31 | 28.9 K | Slatestone Wealth, Llc | 2024-12-31 | 28.4 K | Alyeska Investment Group, L.p. | 2024-12-31 | 11.9 M | Vanguard Group Inc | 2024-12-31 | 1.8 M |
PIII Fundamentals
| Return On Equity | -1.2 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 164.55 M | ||||
| Shares Outstanding | 3.27 M | ||||
| Shares Owned By Insiders | 61.94 % | ||||
| Shares Owned By Institutions | 11.57 % | ||||
| Number Of Shares Shorted | 31.21 K | ||||
| Price To Book | 0.34 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 1.5 B | ||||
| Gross Profit | (64.17 M) | ||||
| EBITDA | (197.76 M) | ||||
| Net Income | (310.38 M) | ||||
| Cash And Equivalents | 63.15 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 166.16 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 0.75 X | ||||
| Book Value Per Share | 19.38 X | ||||
| Cash Flow From Operations | (110.13 M) | ||||
| Short Ratio | 7.16 X | ||||
| Earnings Per Share | (52.42) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 360 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 1.35 B | ||||
| Total Asset | 783.42 M | ||||
| Retained Earnings | (503.19 M) | ||||
| Working Capital | (312.27 M) | ||||
| Net Asset | 783.42 M |
About P3 Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:Check out P3 Health Piotroski F Score and P3 Health Altman Z Score analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (52.42) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.